510(k) Report

510(k) · Cleared

Cleared

Ortho-Mune OK-Combo Control IGG2A-Fitc/IGG2A-PE Monoclonal Antibody (Murine)

K951632510(k) TraditionalCleared Mar 6, 1997699-day reviewClass II21 CFR 864.5220

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ortho Diagnostic Systems, Inc. · GKZ Counter, Differential Cell

Cleared on Mar 6, 1997 as substantially equivalent to K900078 (Bd Becton Dickinson Vacutainer Systems Preanalytic, 1990) and 4 other predicates after a 699-day review. Its family tree reaches back 1 generation to 1990.

Decided
Mar 6, 1997
Review
699 days
Class
Class II
Product code
GKZ
Recalls
None
Predicates
6

Its longest line of descent runs back 1 generation to K900078 (1990). 5 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1996: 4 other ancestorsK900078 · Simultest Imk Plus (TM) · Bd Becton Dickinson Vacutainer Systems Preanalytic · 199019901992199419961998
Other ancestors, by generation 1 generation back: 4 other ancestors K900078 · Simultest Imk Plus (TM) · Bd Becton Dickinson Vacutainer Systems Preanalytic · 19900
  1. Root · 1 generation backK900078 Simultest Imk Plus (TM)Bd Becton Dickinson Vacutainer Systems Preanalytic · 1990
  2. This deviceK951632 Ortho-Mune OK-Combo Control IGG2A-Fitc/IGG2A-PE Monoclonal Antibody…Ortho Diagnostic Systems, Inc. · 1997
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K900078Simultest Imk Plus (TM)Bd Becton Dickinson Vacutainer Systems Preanalytic1990—
0 (this device)K951632Ortho-Mune OK-Combo Control IGG2A-Fitc/IGG2A-PE Monoclonal Antibody (Murine)Ortho Diagnostic Systems, Inc.1997—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199640
FIG. 1 — Lineage of K951632, 1990–1997Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GKZ device

  1. #1 K250943 Sysmex XR-Series (XR-10) Automated Hematology…score 13.2 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (6)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.

TypeNumberDeviceApplicantDecidedRecalls
*K900078Simultest Imk Plus (TM)
Summary page 2
…869-0606 FAX: (908) 218-8168 DEVICE NAME: PREDICATE: Ortho-mune™ OK-COMBO Control Simultest™ IMK Plus 18G,,-FITC/IgG2,-PE Reagent B-Control Monoclonal Antibody (Murine) (K900078) DATE: December 19, 1996 DEVICE DESCRIPTION: Ortho-mune OK-COMBO Control IgG,,-FITC/IgGa.-PE Monoclonal Antibody (Murine) is a…
Bd Becton Dickinson Vacutainer Systems Preanalytic1990—
Kept off the family treeK913912FDA’s K913912 is Verimed Perineometer
Our OCR of the scanned summary read K913912, FDA’s number for Verimed Perineometer (Verimed Holdings, Inc.). Its FDA name has none of the distinctive words the summary uses for the device it names, “Simultest CD3/CD4 (Leu-4/3a)”. Kept off the family tree.
Summary page 12
…s when used with Ortho-mune OK-COMBO Control has been compared to the performance of various other single color and two color reagents and : Simultest CD3/CD4 (Leu-4/3a [K913912] in the following 510(k) Premarket Notifications. t K# | Date Cleared Ortho-mune OK - COMBO CD3-FITC/CD4-PE K950568 May 13, 19…
Verimed Holdings, Inc.1992—
*K950568Ortho-Mune OK-Combo CD3-Fitc/CD4-PE (OKT2/OKT4A) Monoclonal Antibody (Murine)
Cleared while this submission was under review
Summary page 12
…color reagents and : Simultest CD3/CD4 (Leu-4/3a [K913912] in the following 510(k) Premarket Notifications. t K# | Date Cleared Ortho-mune OK - COMBO CD3-FITC/CD4-PE K950568 May 13, 1996 (OKT3/0OKT4A) Ortho-mune OK - COMBO CD3-FITC/CD8-PE K950482 May 10, 1996 (OKT3/OKT8) Ortho-mune OK - COMBO CD4-FI…
Ortho Diagnostic Systems, Inc.1996—
*K950482Ortho-Mune OK-Comvo CD3-Fitc/CD8-PE (Okt 3/OKT8) Monoclonal Antibody (Murine)
Cleared while this submission was under review
Summary page 12
…ng 510(k) Premarket Notifications. t K# | Date Cleared Ortho-mune OK - COMBO CD3-FITC/CD4-PE K950568 May 13, 1996 (OKT3/0OKT4A) Ortho-mune OK - COMBO CD3-FITC/CD8-PE K950482 May 10, 1996 (OKT3/OKT8) Ortho-mune OK - COMBO CD4-FITC/CD8-PE K950625 May 13, 1996 (OKT4A/OKTS) Ortho-mune OK-COMBO CD3-FITC/…
Ortho Diagnostic Systems, Inc.1996—
*K950625Ortho-Mune OK-Combo CD40FITC/CD8-PE (OKT4A/OKT8) Monoclonal Antibody (Murine)
Cleared while this submission was under review
Summary page 12
…COMBO CD3-FITC/CD4-PE K950568 May 13, 1996 (OKT3/0OKT4A) Ortho-mune OK - COMBO CD3-FITC/CD8-PE K950482 May 10, 1996 (OKT3/OKT8) Ortho-mune OK - COMBO CD4-FITC/CD8-PE K950625 May 13, 1996 (OKT4A/OKTS) Ortho-mune OK-COMBO CD3-FITC/CD19-PE K951100 May 13, 1996 (OKT3/0KB19A) CONCLUSION: Performance of O…
Ortho Diagnostic Systems, Inc.1996—
*K951100Ortho-Mune OK-Combo CD3-Fitc/CD19-PE (OKT3/OKB19A Monolclonal Antibody (Murine)
Cleared while this submission was under review
Summary page 12
…- COMBO CD3-FITC/CD8-PE K950482 May 10, 1996 (OKT3/OKT8) Ortho-mune OK - COMBO CD4-FITC/CD8-PE K950625 May 13, 1996 (OKT4A/OKTS) Ortho-mune OK-COMBO CD3-FITC/CD19-PE K951100 May 13, 1996 (OKT3/0KB19A) CONCLUSION: Performance of Ortho-mune OK-COMBO Control IgGy,-FITC/IgG.,-PE Monoclonal Antibody (Muri…
Ortho Diagnostic Systems, Inc.1996—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 5 ancestors has a recall.

How does its category compare?

All GKZ devices

GKZ Counter, Differential Cell: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GKZ

4in 2025

2007: 62008: 62009: 62010: 42011: 32012: 32013: 12014: 32015: 32016: 32017: 42018: 32019: 52020: 12022: 32023: 42024: 32025: 42026 (partial year): 4
2007high 6 (2007) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GKZ

108in 2025

2007: 117 days median2008: 99 days median2009: 147 days median2010: 290 days median2011: 315 days median2012: 408 days median2014: 165 days median2015: 273 days median2016: 198 days median2017: 280 days median2018: 270 days median2019: 210 days median2022: 638 days median2023: 329 days median2024: 157 days median2025: 108 days median2026 (partial year): 254 days median
2007high 638 (2022) · low 99 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GKZ

1in 2025

2007: 372008: 52009: 132010: 272011: 282012: 72013: 62015: 32016: 32017: 32018: 2, 2 Class I2019: 22020: 12022: 42023: 12025: 1
2007high 37 (2007) · low 0 (2014)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · GKZ

77in 2025

2007: 2682008: 9252009: 5592010: 8962011: 2,9052012: 2,9592013: 3,0702014: 3,1122015: 1,9722016: 3,3382017: 2292018: 4972019: 9082020: 3422021: 3912022: 1982023: 1552024: 1152025: 77
2007high 3,338 (2016) · low 77 (2025)2025

MAUDE reports naming product code GKZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007611737268
20086995925
2009614713559
2010429027896
20113315282,905
2012340872,959
20131—63,070
2014316503,112
2015327331,972
2016319833,338
201742803229
201832702 (2)497
201952102908
20201—1342
20210—0391
202236384198
202343291155
202431570115
20254108177
202642540—

What is it indicated for?

Ortho-mune OK-COMBO Control is intended for use as negative control for immunophenotying of human lymphocytes in whole blood by flow cytometry using Ortho-mune OK-COMBO immunophenotyping reagents. Ortho-mune OK-COMBO immunophenotyping reagents are blends of two purified monoclonal antibodies conjugated to fluorescein isothiocyanate and phycoerythrin, respectively. The negative control is used to check for nonspecific background staining and to set the negative/positive rergions of the fluorescent cytograms.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K951632: Ortho-Mune OK-Combo Control IGG2A-Fitc/IGG2A-PE Monoclonal Antibody (Murine).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K951632

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026